Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
2. Study of the Molecular Dynamics Stability in the Inhibitory Interaction of Tenofovir Disoproxil Fumarate against CTLA-4 in Chronic Hepatitis B Patients
- Darmadi D. , et al.
3. Cytokines and Chemokines in HBV Infection
- Zhong S. , et al.
4. Changes of cytokine levels and T cell surface molecules in patients with chronic hepatitis B and the association with functional cure
- Xu Z. , et al.
5. FoxP3, PD-1 and CTLA-4 are decreased significantly after a tenofovir therapy in patients with chronic hepatitis B
- Cho H. , et al.
6. The effects of nucleoside/nucleotide analogues on host immune cells: The baseline for future immune therapy for HBV?
- Boeijen L.L. , et al.
7. Role of immune cells in hepatitis B infection
- Sinha P. , et al.
9. The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeutics
- Gill U.S. , et al.
10. The effect of entecavir therapy on immune status in chronic hepatitis B patients
- Yan H. , et al.
11. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study
- Zhu S. , et al.
12. Current concepts on immunopathogenesis of hepatitis B virus infection
- Peeridogaheh H. , et al.
13. Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment
- Yang X. , et al.
14. Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment
- Guo R. , et al.
15. Th17/Treg cell expression in children with primary nephritic syndrome and the effects of ox-LDL on Th17/Treg cells
- Li Y.Y. , et al.
16. Effect of entecavir on CD4+ T-cell subpopulations in patients with chronic hepatitis B
- Zhan-Fei T. , et al.
17. Role of Tim-3 in hepatitis B virus infection: An overview
- Liu Y. , et al.
18. Association of expression of peripheral CD4+CD25+CD127low/- regulatory T cells with liver pathology and HBV-cccDNA in patients with chronic hepatitis B
- Chao P.P. , et al.
19. Sustained Changes of Treg and Th17 Cells during Interferon-α Therapy in Patients with Chronic Hepatitis B
- Feng H. , et al.
20. Long-term treatment of HBV infection with oral polymerase inhibitors
- van Bömmel F. , et al.
21. Toll-like receptor 2 promotes T helper 17 cells response in hepatitis B virus infection
- Zhao R. , et al.